SynthesisTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2014

Risk/benefit profile of panitumumab-based therapy in patients with metastatic colorectal cancer: evidence from five randomized controlled trials.

Na-Ping Tang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.